Christopher M. Bourne
Impact in
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
-
- Inflammasome and immune disorders 5
- vaccines and immunoinformatics approaches 2
- Oncology 9
- CAR-T cell therapy research 7
- Co-authors
- David A. Scheinberg (10 shared papers)Megan M. Dacek (8 shared papers)Cornelius Y. Taabazuing (5 shared papers)Thomas J. Gardner (6 shared papers)Aaron Y. Chang (2 shared papers)Tao Dao (5 shared papers)Martin G. Klatt (5 shared papers)Renier J. Brentjens (2 shared papers)
- Journals
- Blood (3 papers)Cancer Immunology Research (2 papers)Molecular Therapy (1 paper)Cancers (1 paper)Cells (1 paper)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Christopher M. Bourne
15 papers receiving 257 citations
Peers
Comparison fields: 5 of 52
- Oncology 150
- Immunology 92
- Molecular Biology 121
- Genetics 44
- Biomedical Engineering 59
Countries citing papers authored by Christopher M. Bourne
This map shows the geographic impact of Christopher M. Bourne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher M. Bourne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher M. Bourne more than expected).
Fields of papers citing papers by Christopher M. Bourne
This network shows the impact of papers produced by Christopher M. Bourne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher M. Bourne. The network helps show where Christopher M. Bourne may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher M. Bourne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 58 | |
| 2 | 2023 | 40 | |
| 3 | 2019 | 31 | |
| 4 | 2023 | 29 | |
| 5 | 2020 | 19 | |
| 6 | 2021 | 18 | |
| 7 | 2022 | 15 | |
| 8 | 2021 | 14 | |
| 9 | 2024 | 11 | |
| 10 | 2024 | 9 | |
| 11 | 2022 | 6 | |
| 12 | 2022 | 5 | |
| 13 | 2024 | 4 | |
| 14 | 2023 | 3 | |
| 15 | 2020 | 1 | |
| 16 | 2025 | 0 | |
| 17 | Unintended Consequences of the Goldwater-Nichols Act (Joint Force Quarterly, Spring 1998) | 1998 | 0 |
About Christopher M. Bourne
Christopher M. Bourne is a scholar working on Molecular Biology, Oncology, Immunology, Nephrology and Biomedical Engineering, having authored 17 papers that have together received 263 indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Inflammasome and immune disorders (5 papers), Nanowire Synthesis and Applications (3 papers), Immunotherapy and Immune Responses (3 papers), Gout, Hyperuricemia, Uric Acid (3 papers), Virus-based gene therapy research (2 papers), vaccines and immunoinformatics approaches (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Oncology (150 citations), Immunology (92 citations), Molecular Biology (121 citations), Genetics (44 citations) and Biomedical Engineering (59 citations). Christopher M. Bourne has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include David A. Scheinberg, Megan M. Dacek, Cornelius Y. Taabazuing, Thomas J. Gardner, Aaron Y. Chang, Tao Dao, Martin G. Klatt, Renier J. Brentjens, Bohdana M. Discher and Leila Peraro. Their work appears in journals such as Blood, Cancer Immunology Research, Molecular Therapy, Cancers and Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.